VIRIDIAN THERAPEUTICS INC

$VRDN
Smart money positioned

9 of the Top-200 alpha managers hold $VRDN as of the latest 13F snapshot.

13F holders
216
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

9 holders · Q1 2026

$VRDN is held by 9 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 3.13%, with an average of 0.47% of portfolio. Largest holder: Bellevue Group AG at 3.13%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 216 · Source: 13F-HR
01
Rokos Capital Management LLP
3.13% of portfolio
13,435,030 sh
02
TB Capital Gestao de Recursos Ltda.
0.02% of portfolio
5,590,552 sh
03
Axa S.a.
4,672,885 sh
04
Bienville Capital Management, LLC
2.83% of portfolio
3,882,709 sh
05
VR Adviser, LLC
5.30% of portfolio
3,882,709 sh
06
State Street
3,466,560 sh
07
Fairmount Funds Management LLC
6.72% of portfolio
3,459,913 sh
08
Wealth Dimensions Group, Ltd.
1.26% of portfolio
3,148,893 sh
09
Kynam Capital Management, LP
2.83% of portfolio
2,341,652 sh
10
Siemens Pension Trust E V
0.06% of portfolio
2,315,957 sh
See all 216 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $VRDN in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $VRDN in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 04:23 UTC.